This is a notice of intent for a sole-source, one-year contract with Roche Diagnostics Corporation to provide an automated molecular diagnostic testing platform through a reagent rental arrangement. The performance period is from August 18, 2026, to August 17, 2027, and services will be performed at the NIH Clinical Center to support patient testing. No solicitation document will be issued, and quotations will not be requested, as the acquisition falls under FAR Part 13 Simplified Acquisition Procedures. Interested parties may submit comments to the contract specialist, but the announcement is not a request for competitive quotes.